Bergen Open Research Archive >   Faculty of Medicine >   Institute of Medicine >   Institute of Medicine >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1956/2690

Title:	Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma
Authors:	Heimdal, John-Helge Kross, Kenneth Klementsen, Beate Olofsson, Olaf Aarstad, Hans Jørgen
Issue Date:	30-Jan-2008
Publisher:	BioMed Central
Citation:	BMC Cancer 2008, 8:34
Abstract:	Background This study was performed in order to determine whether monocyte in vitro function is associated with presence, stage and prognosis of head and neck squamous cell carcinoma (HNSCC) disease. Methods Prospective study describing outcome, after at least five years observation, of patients treated for HNSCC disease in relation to their monocyte function. Sixty-five patients with newly diagnosed HNSCC and eighteen control patients were studied. Monocyte responsiveness was assessed by measuring levels of monocyte in vitro interleukin (IL)-6 and monocyte chemotactic peptide (MCP)-1 secretion after 24 hours of endotoxin stimulation in cultures supplied either with 20% autologous serum (AS) or serum free medium (SFM). Survival, and if relevant, cause of death, was determined at least 5 years following primary diagnosis. Results All patients, as a group, had higher in vitro monocyte responsiveness in terms of IL-6 (AS) (t = 2.03; p < 0.05) and MCP-1 (SFM) (t = 2.49; p < 0.05) compared to controls. Increased in vitro monocyte IL-6 endotoxin responsiveness under the SFM condition was associated with decreased survival rate (Hazard ratio (HR) = 2.27; Confidence interval (CI) = 1.05–4.88; p < 0.05). The predictive value of monocyte responsiveness, as measured by IL-6, was also retained when adjusted for age, gender and disease stage of patients (HR = 2.67; CI = 1.03–6.92; p < 0.05). With respect to MCP-1, low endotoxin-stimulated responsiveness (AS), analysed by Kaplan-Meier method, predicted decreased survival (χ = 4.0; p < 0.05). Conclusion In HNSCC patients, changed monocyte in vitro response to endotoxin, as measured by increased IL-6 (SFM) and decreased MCP-1 (AS) responsiveness, are negative prognostic factors.
URI:	http://dx.doi.org/10.1186/1471-2407-8-34 http://hdl.handle.net/1956/2690
Appears in Collections:	Institute of Medicine

Files in This Item: File Description Size Format BIOMed_Stimulated monocyte.pdf 389,04 kB Adobe PDF View/Open

Items in BORA are protected by copyright, with all rights reserved, unless otherwise indicated.